FTM Phalloplasty Candidate

1. Executive Overview: Understanding FTM Phalloplasty

Phalloplasty is a complex, multi-stage reconstructive surgical procedure designed to create a neophallus. For individuals assigned female at birth (AFAB) who experience gender dysphoria, phalloplasty represents the culmination of gender-affirming care. The procedure aims to achieve four primary goals: the ability to void while standing, the creation of a phallus with adequate girth and length for penetrative intercourse, the restoration of erogenous sensation, and a natural aesthetic appearance.

Under the ICD-10 classification F64.0 (Transsexualism), specifically coded as F64.0_3 in many institutional settings for surgical planning, the FTM Phalloplasty candidate undergoes a rigorous screening process. This is not merely a cosmetic intervention but a medically necessary reconstructive surgery to align physiological anatomy with gender identity, significantly improving mental health outcomes and quality of life for patients diagnosed with gender dysphoria.

2. Pathophysiology, Etiology, and Risk Factors

Etiology and Gender Dysphoria

The etiology of gender dysphoria is multifactorial, involving an intricate interplay of neurobiological, hormonal, and psychosocial developmental factors. Current clinical consensus suggests that gender identity is deeply rooted in biological development, with the experience of dysphoria arising when there is a persistent incongruence between one’s gender identity and the sex assigned at birth.

Pathophysiological Considerations

In the context of phalloplasty, the "pathology" is the clinical state of gender dysphoria. The surgical objective is to transition the genital anatomy to match the patient's identity. From a surgical pathophysiology perspective, the challenge lies in the microvascular reconstruction required. The surgeon must harvest a donor site (typically the forearm, thigh, or back) and transfer the tissue, including nerves, arteries, and veins, to the pelvic region to create a functional neophallus.

Risk Factors for Surgical Complications

Candidates must be assessed for surgical readiness based on several risk factors that could impede wound healing or vascular integration:

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of a candidate for FTM Phalloplasty is defined by the World Professional Association for Transgender Health (WPATH) Standards of Care. The hallmark symptom is persistent, intense gender dysphoria related to the primary sex characteristics (genitalia).

Clinical Indicators:

• Persistent Dysphoria: A long-standing, documented history of discomfort with female genitalia.
• Social and Legal Transition: Most candidates have already engaged in social transition and are often on long-term testosterone replacement therapy (TRT).
• Expectation Alignment: The patient displays a realistic understanding of the multi-stage nature of the surgery, the potential for complications, and the limitations of sensory and erectile outcomes.

4. Standard Diagnostic Evaluation & Workup

The diagnostic workup for an FTM Phalloplasty candidate is comprehensive, involving a multidisciplinary team including urologists, plastic surgeons, and mental health professionals.

Pre-Surgical Requirements

1. Psychological Evaluation: Two independent referrals from qualified mental health professionals are typically required to confirm the diagnosis of gender dysphoria and ensure the patient is psychologically prepared for surgery.
2. Hormonal Assessment: Baseline labs (CBC, metabolic panel, hormone levels) are necessary to ensure the patient is in a stable state of systemic health.
3. Anatomical Imaging: In some cases, CT angiography may be performed to assess the vascular anatomy of the donor site (e.g., the radial artery for Radial Forearm Free Flap, or RFF).
4. Urological Assessment: A voiding cystourethrogram or baseline uroflowmetry may be conducted if the patient has had prior hypospadias repair or complex pelvic surgery.

Biopsy and Lab Assays

While there is no "biopsy" for gender dysphoria, routine blood work is essential:
* Hematocrit/Hemoglobin: To ensure the patient can withstand the hemodynamic stress of a long reconstructive procedure.
* Coagulation Profile: To rule out any bleeding disorders that could jeopardize the microvascular anastomosis.

5. Therapeutic Interventions: Surgical and Lifestyle

Surgical Techniques

The choice of donor site is the most critical decision in the surgical planning phase.

• Radial Forearm Free Flap (RFF): The gold standard. Provides excellent sensation due to the inclusion of the lateral antebrachial cutaneous nerve. However, it leaves a donor site scar on the forearm.
• Anterolateral Thigh (ALT) Flap: Preferred if the patient wishes to hide the donor site scar on the leg. It may have less erogenous sensation compared to RFF due to nerve complexity.
• Pedicled Groin Flap: Used less frequently in modern practice due to limited nerve supply.

Pharmacotherapy

• Testosterone Therapy: Patients are typically maintained on testosterone, though they may be asked to pause briefly before surgery depending on the surgeon's protocol regarding clotting risks.
• Post-Operative Antibiotics: Prophylactic antibiotics are mandatory to prevent infection of the graft site.

Lifestyle and Long-Term Prognosis

Long-term prognosis is generally excellent, with high rates of patient satisfaction. Patients must understand that "lifestyle" after surgery involves:
1. Pelvic Floor Physical Therapy: Crucial for managing urinary function.
2. Dilatation: If urethral lengthening (phalloplasty with urethral reconstruction) is performed, patients must follow strict protocols to prevent strictures.
3. Sexual Function: The use of external devices or internal implants (penile prostheses) is often required to achieve rigidity for intercourse.

6. Frequently Asked Questions (FAQ)

1. What is the difference between phalloplasty and metoidioplasty?
Metoidioplasty uses existing clitoral tissue enlarged by testosterone to create a small phallus. Phalloplasty is a full reconstruction using skin grafts from other parts of the body to create a larger phallus.

2. How many stages does the phalloplasty process involve?
It is typically a multi-stage process, often involving 2 to 4 major surgeries spread over 12–18 months to account for healing and secondary revisions.

3. Will I have sensation in my neophallus?
Yes. By connecting the nerves from the donor tissue to the nerves in the pelvic region, most patients achieve tactile sensation and erogenous sensation over time.

4. Can I urinate while standing after the surgery?
Yes, if a urethral lengthening procedure is performed, which connects the native urethra to the neophallus.

5. What is the recovery time for phalloplasty?
Initial recovery in the hospital is usually 5–7 days, with a return to light activity in 6–8 weeks. Full healing can take up to a year.

6. Are there risks of the graft failing?
Yes, total or partial flap necrosis is a rare but serious risk, particularly in smokers.

7. Does insurance cover phalloplasty?
In many jurisdictions, phalloplasty is considered medically necessary for the treatment of gender dysphoria and is covered by insurance, provided the WPATH criteria are met.

8. Can I have sexual intercourse after phalloplasty?
Yes. Depending on the size achieved and the use of a penile implant (prosthesis), patients can engage in penetrative intercourse.

9. What happens to the donor site?
The donor site (arm or leg) is usually closed with a skin graft. It will have a permanent scar, which can be managed with physical therapy and scar treatments.

10. Is this surgery reversible?
No. Phalloplasty is an irreversible, permanent reconstructive surgery. It requires a high level of clinical certainty and psychological stability.

Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Patients should consult with a board-certified reconstructive surgeon specializing in gender-affirming procedures to discuss their individual clinical needs.